MedPath

Non-invasive Determination of Anemia in Children With Renal Failure

Completed
Conditions
Renal Failure
Registration Number
NCT02369237
Lead Sponsor
Center for Studies of Sensory Impairment, Aging and Metabolism
Brief Summary

Anemia and inflammation are very common in patients with renal diseases. The most common procedure to detect anemia is to determine blood hemoglobin concentrations. The Haemospect® is a portable device for non-invasive hemoglobin determination that works with a sensor that is applicable in infants and adults alike.

The objective of this trial is to collect spectra with the non-invasive Haemospect® device in children of different age groups with renal failure and different hemoglobin concentrations. In parallel, corresponding hemoglobin values shall be obtained invasively to form the basis for the development of an algorithm for the device.

To determine inflammation, the frequencies of vasomotion and oxygenation of the tissue are measured non-invasively with the Haemospect®. Various blood parameters for iron and inflammation will also be determined, such as ferritin, hepcidin, transferrin, serum iron, white blood cell count and CRP.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • all children in treatment for renal insufficiency in FUNDANIER
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglobin1 day
Iron parameters1 day

Serum iron, ferritin, transferrin, transferrin saturation, TIBC, hepcidin

Inflammation parameters1 day

Ferritin, hepcidin, CRP, white blood cell count, ESR

Secondary Outcome Measures
NameTimeMethod
anthropometric data1 day

weight, height, WAZ, HAZ and WHZ

© Copyright 2025. All Rights Reserved by MedPath